Which Myeloma Patients Are Candidates for CAR T-Cell Therapy?
https://vimeo.com/779453039 Myeloma specialist Dr. Omar Nadeem discusses which patients are most appropriate for CAR T-cell therapy and explains cytokine release syndrome (CRS), which may arise following this treatment approach. Dr….
How Is Relapsed or Refractory Myeloma Managed?
https://vimeo.com/779452757 Drs. Irene Ghobrial and Betsy O’Donnell discuss next steps if myeloma relapse occurs or the disease doesn’t respond to treatment. The experts review the necessary tests following a myeloma…
How Are Patients on Myeloma Maintenance Therapy Monitored?
https://vimeo.com/779453217 Myeloma specialist Dr. Omar Nadeem explains how a follow-up care and monitoring plan for patients on maintenance therapy is determined. Dr. Omar Nadeem is the Clinical Director of the…
How Is Research Advancing Myeloma Treatment and Care?
https://vimeo.com/779453322 A panel of myeloma experts, including Drs. Omar Nadeem, Irene Ghobrial, and Betsy O’Donnell, discuss how clinical trials advance myeloma research and share an update on promising therapies in…
What Are Currently Available Myeloma Treatments?
https://vimeo.com/779453261 Dr. Omar Nadeem reviews myeloma treatment classes, including immunomodulatory therapies, proteasome inhibitors, and monoclonal antibodies. Dr. Nadeem also discusses how combining these therapies has boosted the effectiveness of myeloma…
Understanding Personalized Medicine for Myeloma
https://vimeo.com/779453431 Myeloma experts Dr. Omar Nadeem and Dr. Betsy O’Donnell discuss the personalized approach to treating myeloma and the factors that are considered when making care decisions. Dr. Omar Nadeem…
How Is MGUS Monitored?
https://vimeo.com/779453510 Myeloma expert Dr. Irene Ghobrial discusses how patients with monoclonal gammopathy of undetermined significance (MGUS) are monitored over time and shares an update on research being conducted to learn…
What Should Patients Know About Myeloma Testing?
https://vimeo.com/779453701 Testing following a myeloma diagnosis, or relapse, can impact care and treatment decisions. Drs. Betsy O’Donnell and Omar Nadeem provide an overview of essential myeloma testing, how the test…
Understanding MGUS & Smoldering Myeloma: What’s the Difference?
https://vimeo.com/779453854 Myeloma expert Dr. Irene Ghobrial explains the difference between the precursor conditions, MGUS (monocloncal gammopathy of undetermined significance) and smoldering myeloma, including how these conditions are detected. Dr. Irene…
Health Equity: Accessing Quality MPN Care and Clinical Trials
https://vimeo.com/779450907 How can health equity be addressed in MPN care? Dr. Angela Fleischman discusses the importance of clinical trial diversity and ways to help provide equitable MPN care for all…
Resources for Accessing MPN Clinical Trials
https://vimeo.com/779450853 What are credible resources for accessing MPN clinical trials? Dr. Angela Fleischman shares credible resources for MPN patients and advice for inquire about clinical trial participation. Dr. Angela Fleischman…
The Risks and Benefits of Participating in an MPN Clinical Trial
https://vimeo.com/779450700 What are the risks and benefits of MPN clinical trial participation? Dr. Angela Fleischman discusses clinical trial risks, benefits, safety protocols, monitoring, and importance of clinical trial participation. Dr….